Skip to main content

Peer Review reports

From: HMGCR gene polymorphism is associated with residual cholesterol risk in premature triple-vessel disease patients treated with moderate-intensity statins

Original Submission
16 Nov 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
18 Apr 2023 Reviewed Reviewer Report - Gilberto Vargas-Alarcon
19 Apr 2023 Reviewed Reviewer Report
26 Apr 2023 Author responded Author comments - Xueyan Zhao
Resubmission - Version 4
26 Apr 2023 Submitted Manuscript version 4
1 May 2023 Reviewed Reviewer Report
3 May 2023 Reviewed Reviewer Report - Gilberto Vargas-Alarcon
8 May 2023 Author responded Author comments - Xueyan Zhao
Resubmission - Version 5
8 May 2023 Submitted Manuscript version 5
Publishing
8 May 2023 Editorially accepted
24 Jun 2023 Article published 10.1186/s12872-023-03285-w

You can find further information about peer review here.

Back to article page